急性心肌梗死生化标志物研究进展

Research Advancements for Biomarkers Used in Acute Myocardial Infarction

急性心肌梗死是临床常见的危重疾病,早期确诊、及时溶栓是挽救患者生命的重要前提。生化标志物在AMI的诊断中具有高度的敏感性和特异性,对AMI的早期诊断、危险分层及预后评估具有重要作用。目前,AMI相关生化标志物检测在临床中已被广泛应用,本文将对急性心肌梗死生化标志物研究进展进行综述。

Acute myocardial infarction（AMI）is a common clinical critical illness,Early diagnosis and timely thrombolysis are important prerequisite to save the patient’s life.There is a high degree of sensitivity and specificity to biochemical markers in the diagnosis of AMI,which has an important role to early diagnosis,risk stratification and prognosis of AMI.AMI related biochemical markers detecting has been widely used in the clinical,This article reviews current research in this field.